Published in J Invasive Cardiol on April 01, 2010
Patent foramen ovale: anatomy, outcomes, and closure. Nat Rev Cardiol (2011) 1.57
Mid-term results of interventional closure of patent foramen ovale with the Occlutech Figulla(®) Flex II Occluder. BMC Cardiovasc Disord (2016) 0.75
Quest for the ideal ASD/PFO closure device continues. J Invasive Cardiol (2010) 0.75
Transcatheter closure of atrial septal defect in a patient with cor triatriatum sinister and atrial septal defect. Case Rep Cardiol (2011) 0.75
Comparison of the Occlutech ® Figulla ® septal occluder and Amplatzer ® septal occluder for atrial septal defect device closure. Pediatr Cardiol (2015) 0.75
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet (2009) 10.53
Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. J Am Coll Cardiol (2004) 5.44
Cerebral embolization during transcatheter aortic valve implantation: a transcranial Doppler study. Circulation (2012) 3.70
Prospective, multicenter European study of the GORE flow reversal system for providing neuroprotection during carotid artery stenting. Catheter Cardiovasc Interv (2012) 3.32
Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J (2010) 3.26
Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. J Am Coll Cardiol (2013) 2.97
Does the presence of accessory renal arteries affect the efficacy of renal denervation? JACC Cardiovasc Interv (2013) 2.90
Multicenter USA Amplatzer patent ductus arteriosus occlusion device trial: initial and one-year results. J Am Coll Cardiol (2004) 2.86
Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience. Catheter Cardiovasc Interv (2011) 2.67
In-hospital outcomes of percutaneous coronary intervention in patients with chronic total occlusion: insights from the ERCTO (European Registry of Chronic Total Occlusion) registry. EuroIntervention (2011) 2.63
Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry. Circ Heart Fail (2012) 2.41
Paravalvular leak closure after transcatheter aortic valve replacement with a self-expanding prosthesis. Catheter Cardiovasc Interv (2013) 2.25
Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials. J Am Coll Cardiol (2005) 2.19
Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registry. J Am Coll Cardiol (2009) 2.12
New onset atrial fibrillation after patent foramen ovale closure. Catheter Cardiovasc Interv (2009) 2.08
Proximal endovascular flow blockage for cerebral protection during carotid artery stenting: results from a prospective multicenter registry. J Endovasc Ther (2005) 2.03
Clinical efficacy and safety of an implantable cardioverter-defibrillator lead with a floating atrial sensing dipole. Pacing Clin Electrophysiol (2013) 2.02
Renal denervation. Anadolu Kardiyol Derg (2014) 1.96
Valve-in-valve transcatheter aortic valve implantation for degenerated bioprosthetic heart valves. JACC Cardiovasc Interv (2011) 1.94
The role of a pseudo-response regulator gene in life cycle adaptation and domestication of beet. Curr Biol (2012) 1.94
Noninvasive visualization of coronary artery bypass grafts using 16-detector row computed tomography. J Am Coll Cardiol (2004) 1.90
Expert consensus document from the European Society of Cardiology on catheter-based renal denervation. Eur Heart J (2013) 1.90
Transcatheter closure of congenital ventricular septal defects: results of the European Registry. Eur Heart J (2007) 1.89
Intracardiac echocardiography is superior to conventional monitoring for guiding device closure of interatrial communications. Circulation (2003) 1.85
A randomized trial of polytetrafluoroethylene-membrane-covered stents compared with conventional stents in aortocoronary saphenous vein grafts. J Am Coll Cardiol (2003) 1.85
Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology). J Am Coll Cardiol (2013) 1.82
Technical advances in total aortic arch replacement. Ann Thorac Surg (2004) 1.75
Optimal timing of invasive angiography in stable non-ST-elevation myocardial infarction: the Leipzig Immediate versus early and late PercutaneouS coronary Intervention triAl in NSTEMI (LIPSIA-NSTEMI Trial). Eur Heart J (2011) 1.75
Closure of atrial septal defect with the Amplatzer septal occluder in adults. Am J Cardiol (2008) 1.69
LIFEBRIDGE: a portable, modular, rapidly available "plug-and-play" mechanical circulatory support system. Ann Thorac Surg (2005) 1.66
International study on microcirculatory shock occurrence in acutely ill patients. Crit Care Med (2015) 1.64
Serum concentration of NSE and S-100b during LVAD in non-resuscitated patients. Resuscitation (2008) 1.64
European Registry of Carotid Artery Stenting: results from a prospective registry of eight high volume EUROPEAN institutions. Catheter Cardiovasc Interv (2012) 1.61
Hybrid operating room concept for combined diagnostics, intervention and surgery in acute type A dissection. Eur J Cardiothorac Surg (2012) 1.59
Axillary artery cannulation: routine use in ascending aorta and aortic arch replacement. Ann Thorac Surg (2004) 1.59
One-year outcome of percutaneous rotational atherectomy with aspiration in infrainguinal peripheral arterial occlusive disease: the multicenter pathway PVD trial. J Endovasc Ther (2009) 1.53
Transcatheter aortic valve implantation in patients with low-flow, low-gradient aortic stenosis. JACC Cardiovasc Interv (2012) 1.49
Detection of irregular patterns of myocardial contraction in patients with hypertensive heart disease: a two-dimensional ultrasound speckle tracking study. J Hypertens (2011) 1.47
Safety of percutaneous left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation and contraindications to anticoagulation. Catheter Cardiovasc Interv (2014) 1.47
Impact of aortic valve calcification on the outcome of transcatheter aortic valve implantation: results from the prospective multicenter German TAVI registry. Catheter Cardiovasc Interv (2012) 1.46
Percutaneous femoral arteriovenous shunt creation for advanced chronic obstructive pulmonary disease: a single-center safety and efficacy study. Circ Cardiovasc Interv (2012) 1.46
A meta-analysis of proximal occlusion device outcomes in carotid artery stenting. Catheter Cardiovasc Interv (2012) 1.45
Development of bladder outlet obstruction after a single treatment of prostate cancer with high-intensity focused ultrasound: experience with 226 patients. J Endourol (2010) 1.45
Long-term results of a randomized trial comparing three different devices for percutaneous closure of a patent foramen ovale. Eur Heart J (2013) 1.44
Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study. Catheter Cardiovasc Interv (2012) 1.44
Comparison of pre-hospital combination-fibrinolysis plus conventional care with pre-hospital combination-fibrinolysis plus facilitated percutaneous coronary intervention in acute myocardial infarction. Eur Heart J (2005) 1.44
Initial human experience with the Amplatzer perimembranous ventricular septal occluder device. Catheter Cardiovasc Interv (2003) 1.44
The complex structure of the smooth muscle layer of spermatic veins and its potential role in the development of varicocele testis. Eur Urol (2006) 1.43
Complications of carotid stenting during live transmissions. JACC Cardiovasc Interv (2009) 1.42
Classification for carotid artery stenting complications: manifestation, management, and prevention. J Endovasc Ther (2010) 1.42
A suture not always the ideal solution: problems encountered in developing a suture-based PFO closure technique. Catheter Cardiovasc Interv (2009) 1.40
Coronary sinus reducer stent for the treatment of chronic refractory angina pectoris: a prospective, open-label, multicenter, safety feasibility first-in-man study. J Am Coll Cardiol (2007) 1.40
Early experience of percutaneous paravalvular leak closure using a novel Occlutech occluder. EuroIntervention (2016) 1.40
Determinants of coronary steal in chronic total coronary occlusions donor artery, collateral, and microvascular resistance. J Am Coll Cardiol (2006) 1.40
Comparison of surgical, stent, and balloon angioplasty treatment of native coarctation of the aorta: an observational study by the CCISC (Congenital Cardiovascular Interventional Study Consortium). J Am Coll Cardiol (2011) 1.39
Mitral Annuloplasty Device Implantation for Non-Surgical Treatment of Mitral Regurgitation: Clinical Experience After the Approval Studies. J Invasive Cardiol (2016) 1.39
A novel approach to treat residual peridevice leakage after left-atrial appendage closure. Catheter Cardiovasc Interv (2013) 1.38
Identification of "substrate fibrillators" and "trigger fibrillators" by pacemaker diagnostics. Heart Rhythm (2006) 1.38
Transseptal strategy in retrograde transcatheter valve-in-valve implantation for failed surgical aortic bioprosthesis. Catheter Cardiovasc Interv (2014) 1.38
Management of high-risk patients with aortic stenosis and coronary artery disease. Ann Thorac Surg (2012) 1.38
Recurrent events after percutaneous closure of patent foramen ovale. Catheter Cardiovasc Interv (2013) 1.37
Photoablation using the turbo-booster and excimer laser for in-stent restenosis treatment: twelve-month results from the PATENT study. J Endovasc Ther (2014) 1.37
European perspective in the recanalisation of Chronic Total Occlusions (CTO): consensus document from the EuroCTO Club. EuroIntervention (2007) 1.36
PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study. EuroIntervention (2010) 1.34
Procedural results and acute complications in stenting native and recurrent coarctation of the aorta in patients over 4 years of age: a multi-institutional study. Catheter Cardiovasc Interv (2007) 1.30
Angiographic assessment of collateral connections in comparison with invasively determined collateral function in chronic coronary occlusions. Circulation (2003) 1.29
Renal artery stenosis after renal sympathetic denervation. J Am Coll Cardiol (2012) 1.29
Renal denervation: tips and tricks to perform a technically successful procedure. EuroIntervention (2013) 1.28
Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal? Cardiovasc Res (2013) 1.21
Genetic and physical maps around the sex-determining M-locus of the dioecious plant asparagus. Mol Genet Genomics (2007) 1.19
PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway. Am J Physiol Heart Circ Physiol (2009) 1.19
Predictors of death and stroke after carotid angioplasty and stenting: a subgroup analysis of the Pro-CAS data. Stroke (2008) 1.18
Use of real time three-dimensional transesophageal echocardiography in intracardiac catheter based interventions. J Am Soc Echocardiogr (2009) 1.17
Arginase inhibition improves endothelial function in patients with coronary artery disease and type 2 diabetes mellitus. Circulation (2012) 1.14
Intermediate follow-up following intravascular stenting for treatment of coarctation of the aorta. Catheter Cardiovasc Interv (2007) 1.13
Percutaneous closure of perivalvular leaks with Amplatzer occluders: feasibility, safety, and shortterm results. J Heart Valve Dis (2007) 1.13
Stenting of aortic coarctation: acute, intermediate, and long-term results of a prospective multi-institutional registry--Congenital Cardiovascular Interventional Study Consortium (CCISC). Catheter Cardiovasc Interv (2010) 1.12
Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug. EuroIntervention (2016) 1.11
Human experience with transvenous biventricular defibrillation using an electrode in a left ventricular vein. Pacing Clin Electrophysiol (2002) 1.10
The functional reserve of collaterals supplying long-term chronic total coronary occlusions in patients without prior myocardial infarction. Eur Heart J (2006) 1.10
Impact of atherosclerotic plaque composition on coronary microembolization during percutaneous coronary interventions. Basic Res Cardiol (2008) 1.09
MitraClip therapy in daily clinical practice: initial results from the German transcatheter mitral valve interventions (TRAMI) registry. Eur J Heart Fail (2012) 1.09
Analysis of DNA polymorphisms in sugar beet (Beta vulgaris L.) and development of an SNP-based map of expressed genes. Theor Appl Genet (2007) 1.08
Time course of hepatitis A viremia and viral load in the blood of human hepatitis A patients. J Med Virol (2004) 1.08
Outcomes and risks of operative treatment of rupture of the anterior cruciate ligament in children and adolescents. Arthroscopy (2010) 1.08
Flowering time variation in oilseed rape (Brassica napus L.) is associated with allelic variation in the FRIGIDA homologue BnaA.FRI.a. J Exp Bot (2011) 1.07
The promoter of the nematode resistance gene Hs1pro-1 activates a nematode-responsive and feeding site-specific gene expression in sugar beet (Beta vulgaris L.) and Arabidopsis thaliana. Plant Mol Biol (2003) 1.07
Management of tricuspid regurgitation by caval valve implantation: from technical feasibility to evaluation of efficacy. J Am Coll Cardiol (2013) 1.07
Arginase inhibition restores in vivo coronary microvascular function in type 2 diabetic rats. Am J Physiol Heart Circ Physiol (2011) 1.06
Transcatheter treatment of atrial septal aneurysm associated with patent foramen ovale for prevention of recurrent paradoxical embolism in high-risk patients. J Am Coll Cardiol (2005) 1.05